ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business

Japanese companies ramping up regenerative products

TOKYO -- Two Japanese medical equipment and pharmaceutical companies are accelerating efforts to put their regenerative medicine businesses to commercial use, as Japan has revised a law to help catch up with the U.S. and Europe in making regenerative medicine products.

A worker at Terumo prepares medical equipment in Kanagawa Prefecture. The company will set up a production system for making cell sheets for cardiac arrest at its research and development center there in the spring.

     Terumo will start producing for sale cell sheets for cardiac arrest, called HeartSheet, in April this year. In September 2015 the Tokyo-based medical equipment company received official approval for producing and selling these cell sheets that are made from human cells.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more